Suchergebnisse - "Ziv, Amit"

PubPharm (25)

1

THE 12TH CONGRESS OF THE INTERNATIONAL SOCIETY OF SYSTEMIC AUTOINFLAMMATORY DISEASES (ISSAID) HELD ON 15-18 MAY 2023, TORONTO, CANADA

enthalten in: Harefuah | 2024

von Ziv, A. | Haviv, R. | Uziel, Y.

2

Influenza vaccine uptake in juvenile idiopathic arthritis : a multi-centre cross-sectional study

enthalten in: European journal of pediatrics | 2024

von Maritsi, D. | Dasoula, F. | Ziv, A. | +11

3

The impact of the COVID-19 pandemic on pediatric rheumatology practice : an international, cross-sectional survey study

enthalten in: Seminars in arthritis and rheumatism | 2023

von Batu, E. | Demirkan, F. | Sag, E. | +8

4

Safety and Immunogenicity Following the Second and Third Doses of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents with Juvenile-Onset Autoimmune Inflammatory Rheumatic Diseases : A Prospective Multicentre Study

enthalten in: Vaccines | 2023

von Heshin-Bekenstein, M. | Ziv, A. | Toplak, N. | +10

5

Effectiveness of the BNT162b2 mRNA COVID-19 vaccine among adolescents with juvenile-onset inflammatory rheumatic diseases

enthalten in: Rheumatology (Oxford, England) | 2023

von Ziv, A. | Heshin-Bekenstein, M. | Haviv, R. | +9

6

Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients

enthalten in: Clinical rheumatology | 2022

von Pri-Paz Basson, Y. | Tayer-Shifman, O. | Naser, R. | +9

ErratumIn: Clin Rheumatol. 2022 Oct 17;:. - PMID 36251175

7

Correction to : Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients

enthalten in: Clinical rheumatology | 2022

von Pri-Paz Basson, Y. | Tayer-Shifman, O. | Naser, R. | +9

ErratumFor: Clin Rheumatol. 2022 Dec;41(12):3879-3885. - PMID 36050514

8

Measuring the knowledge of juvenile idiopathic arthritis among Israeli paediatricians and paediatric orthopaedic surgeons : what needs to be improved?

enthalten in: Clinical and experimental rheumatology | 2022

von Schujovitzky, D. | Ziv, A. | Heshin Bekenstein, M. | +5

9

Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications

enthalten in: Rheumatology (Oxford, England) | 2022

von Heshin-Bekenstein, M. | Ziv, A. | Toplak, N. | +10

CommentIn: Rheumatology (Oxford). 2022 Nov 2;61(11):4229-4231. - PMID 35916712

10

Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients

enthalten in: Clinical rheumatology | 2022

von Pri-Paz Basson, Y. | Tayer-Shifman, O. | Naser, R. | +9